| 1. | | Recruiting | Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: refractory chronic lymphocytic leukemia; noncontiguous stage II small lymphocytic lymphoma; recurrent small lymphocytic lymphoma; ... |
| 2. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 3. | | Recruiting | Oral Enzastaurin HCl in Patients with Relapsed Mantle Cell Lymphoma
Condition: Mantle-Cell Lymphoma |
| 4. | | Recruiting | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma |
| 5. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; recurrent adult diffuse large cell lymphoma; recurrent adult Hodgkin's lymphoma |
| 6. | | Not yet recruiting | BCX-1777 in Treating Patients With Recurrent or Refractory Advanced T-Cell Leukemia or T-Cell Lymphoma
Conditions: acute leukemia; adult T-cell leukemia and lymphoma; childhood lymphoblastic lymphoma; Non-Hodgkin's Lymphoma; Prolymphocytic Leukemia |
| 7. | | Recruiting | A Pilot Study of Pivanex in Patients with Chronic Lymphocytic Leukemia
Conditions: Leukemia, Lymphocytic, Chronic; Lymphoma, Small Lymphocytic |
| 8. | | Recruiting | Comparison of Two Induction Combination Chemotherapy Regimens Followed By High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With or Without Rituximab as Maintenance Therapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: recurrent adult diffuse large cell lymphoma |
| 9. | | Recruiting | Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 10. | | Recruiting | FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent small lymphocytic lymphoma |
| 11. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 12. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
| 13. | | Not yet recruiting | Comparative Trial between Bexxar and Zevalin
Conditions: Follicular Lymphoma; Diffuse Large Cell Lymphoma |
| 14. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma |
| 15. | | Recruiting | Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
| 16. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
| 17. | | Recruiting | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 18. | | Recruiting | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Conditions: recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 19. | | Recruiting | Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
Conditions: recurrent childhood lymphoblastic lymphoma; recurrent childhood small noncleaved cell lymphoma; recurrent childhood large cell lymphoma; ... |
| 20. | | Recruiting | Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
Condition: recurrent adult diffuse large cell lymphoma |
| 21. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ... |
| 22. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
| 23. | | Recruiting | Dose ranging trial for pixantrone in the FND-R variant regimen in indolent non-Hodgkin's lymphoma
Conditions: Lymphoma, Low-Grade; Lymphoma, Small Lymphocytic; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular |
| 24. | | Recruiting | MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ... |
| 25. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Conditions: acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma |
| 26. | | Recruiting | Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Conditions: noncontiguous stage II adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma |
| 27. | | Recruiting | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Older Patients With Previously Untreated Non-Hodgkin's Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 28. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 29. | | Recruiting | Bortezomib With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent grade 3 follicular lymphoma |
| 30. | | Recruiting | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Conditions: acute leukemia; childhood large cell lymphoma; childhood small noncleaved cell lymphoma; Drug Toxicity |
| 31. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
| 32. | | Recruiting | Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; childhood diffuse large cell lymphoma; childhood large cell lymphoma |
| 33. | | Recruiting | LY317615 in Treating Patients With Relapsed or Refractory Lymphoma
Condition: recurrent adult diffuse large cell lymphoma |
| 34. | | Recruiting | Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
Conditions: stage III mantle cell lymphoma; stage IV mantle cell lymphoma; stage II mantle cell lymphoma |
| 35. | | Recruiting | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
| 36. | | Recruiting | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
| 37. | | Recruiting | Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
Condition: Lymphoma, Mantle-Cell |
| 38. | | Recruiting | Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma
Conditions: AIDS-Related Lymphoma; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; ... |
| 39. | | Recruiting | Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
| 40. | | Recruiting | Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
Conditions: acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ... |
| 41. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
| 42. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
| 43. | | Recruiting | Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
| 44. | | Recruiting | Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ... |
| 45. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma |
| 46. | | Recruiting | Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer
Conditions: refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma |
| 47. | | Recruiting | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
| 48. | | Recruiting | Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma
Conditions: stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ... |
| 49. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 50. | | Recruiting | 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma |
